Sooma starts a collaboration with the Non-Invasive Brain Stimulation Lab at University Medical Center (Göttingen)
Sooma and the Non-Invasive Brain Stimulation (NBS) Lab have kick-started a collaboration to conduct a clinical trial with 80 participants from all over Germany. The clinical study uses a novel, innovative therapeutic approach that combines mindfulness meditation and tDCS to treat fibromyalgia. The research is being conducted by PhD student Perianen Ramasawmy and his team: Luise Heim, Elisabeth Fechner and Samuel Schumann— under the supervision of Prof. Andrea Antal, leader and head of the NBS Lab, and Prof. Frank Petzke, head of the Dept. of Anesthesiology at the University Medical Center Göttingen (UMG).
The team received a face-to-face training session by Sooma specialists last July, during the celebration of the 18th Practical Course in Transcranial Brain Stimulation: Best Practice within the framework of the training program of the German Neuroscience Society (NWG), where Sooma participated as one of the industry sponsors.
Focused on understanding externally applied neuroplasticity using various non-invasive brain stimulation techniques such as tDCS, the NBS Lab, located in the Dept. of Neurology at the UMG, also establishes and develops novel protocols for the treatment of neurological diseases such as chronic pain and cognitive impairments.
Thanks to the simplicity of use and dosage reproducibility of Sooma tDCS, most of the patients in the trial will be able to follow the combined treatment from home.
To read more about the study, you can access its file at the German Clinical Trial Register official website.
TDCS is the treatment method offered by Sooma for depression (Sooma Depression Therapy, indicated for Major Depressive Disorder) and chronic pain (Sooma Pain Therapy, indicated for Fibromyalgia and chronic neuropathic pain). By using Sooma devices, you ensure that you are performing a safe and effective patient treatment, should be it in the hospital or at patients’ homes, with legal, regulated, tested, and effective equipment that complies with the latest EU regulations and features all the recommended elements listed on this article.
Latest news
Sooma Partners with JSTT to Introduce Brain Stimulation Treatments in Occupational Healthcare
Read more
Prioritizing Youth Mental Health: A Call to Action
Read more
Sooma Secures €5M Funding for At-home Brain Stimulation Therapies
Read more